查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771031

獸醫 CRO 和 CDMO 市場 - 全球產業規模、佔有率、趨勢、機會和預測（按動物、服務、應用、地區和競爭細分，2020-2030 年）

Veterinary CRO And CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal, By Service, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫合約研究組織 (CRO) 和合約製造生產組織 (CDMO) 市場規模預計在 2024 年達到 57.8 億美元，到 2030 年將達到 96.5 億美元，年複合成長率為 8.90%。製藥和生物技術公司擴大將研發和生產外包，以減輕營運負擔並加快進度，這推動了這一成長。獸醫治療藥物、疫苗和生物製劑的需求不斷成長，尤其是伴侶動物和牲畜的需求，這加劇了對成本效益高且合規的合約組織的需求。合約研究組織 (CRO) 支援臨床和監管職能，而合約製造生產組織 (CDMO) 則提供從製劑到商業生產的全方位服務。此外，人畜共通傳染病和傳染病威脅的激增也加大了動物保健領域的研發投入，從而刺激了專業外包合作夥伴市場的發展。影響市場的一個主要趨勢是 CRO、CDMO 和獸藥開發商之間的策略合作和收購不斷增加，這是由擴大全球影響力和在臨床研究中整合數位工具和生物標記研究等技術支援平台的需求所推動的。

市場概覽
預測期 2026-2030
2024年市場規模 57.8億美元
2030年市場規模 96.5億美元
2025-2030 年複合年成長率 8.90%
成長最快的領域 醫療器材
最大的市場 北美洲

關鍵市場促進因素

伴侶動物擁有量和醫療保健支出的增加

主要市場挑戰

熟練獸醫研究專業人員數量有限

主要市場趨勢

生物製劑和先進獸醫治療藥物的需求增加

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球獸醫CRO與CDMO市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按動物（伴侶動物、牲畜）
    • 按服務（發現、開發、製造、包裝和標籤、市場批准和上市後）
    • 依應用（藥品、生物製劑、醫療器材、其他）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美獸醫CRO與CDMO市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲獸醫CRO和CDMO市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太獸醫CRO和CDMO市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美獸醫CRO和CDMO市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲獸醫CRO和CDMO市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet (Pty) Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29982

The Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by the increasing tendency of pharmaceutical and biotechnology firms to outsource research, development, and manufacturing to reduce operational loads and accelerate timelines. Rising demand for veterinary therapeutics, vaccines, and biologics-particularly for companion animals and livestock-has amplified the need for cost-efficient and compliant contract organizations. CROs support clinical and regulatory functions, while CDMOs offer full-spectrum services from formulation to commercial manufacturing. Additionally, the surge in zoonotic diseases and infectious threats has intensified R&D investments in animal health, boosting the market for specialized outsourcing partners. A major trend influencing the market is the uptick in strategic collaborations and acquisitions among CROs, CDMOs, and veterinary drug developers, driven by the need to broaden global presence and integrate tech-enabled platforms like digital tools and biomarker studies in clinical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.78 Billion
Market Size 2030USD 9.65 Billion
CAGR 2025-20308.90%
Fastest Growing SegmentMedical Devices
Largest MarketNorth America

Key Market Drivers

Increase in Companion Animal Ownership and Healthcare Spending

The growing number of companion animals and rising expenditure on their healthcare are pivotal factors driving the Veterinary CRO and CDMO market. Increasingly, pets are being viewed as family members, reshaping consumer spending patterns. According to the 2024 Pet Ownership Survey by the American Veterinary Medical Association, 45.5% of U.S. households own dogs and 32.1% own cats-amounting to nearly 90 million dogs and 74 million cats. Annual veterinary spending averages USD 580 per dog and USD 433 per cat. This surge in pet population and associated healthcare costs has led pharmaceutical and biotech companies to expand their veterinary pipelines, thereby increasing the demand for outsourced R&D and manufacturing services.

Key Market Challenges

Limited Availability of Skilled Veterinary Research Professionals

A significant hurdle in the Global Veterinary CRO and CDMO Market is the shortage of skilled veterinary research professionals. Veterinary clinical and preclinical studies require specialized knowledge across diverse species, drug mechanisms, behavioral patterns, and compliance standards. Unlike human trials, veterinary research spans a wide array of animals-companion pets, livestock, equines, and exotic species-each with unique biological needs. This diversity demands expertise in veterinary science, clinical trial methodologies, ethical considerations, and animal care protocols. However, a global shortfall of such multidisciplinary professionals hampers the scalability, timeline adherence, and quality maintenance capabilities of CROs and CDMOs.

Key Market Trends

Increased Demand for Biologics and Advanced Veterinary Therapeutics

The demand for biologics and next-generation veterinary therapeutics is significantly shaping the Veterinary CRO and CDMO market. As animal health issues become more complex, there's a growing preference for high-efficacy biologics like monoclonal antibodies, recombinant proteins, and DNA-based vaccines over traditional small-molecule drugs. These innovative solutions are being developed to address serious conditions such as cancer, autoimmune diseases, and chronic infections in both companion and farm animals. This trend is expanding the need for specialized services from CROs and CDMOs, including immunogenicity evaluations, bioanalytical testing, and biologics manufacturing under high-containment protocols. The advanced infrastructure and analytical capabilities required for biologics are fueling the reliance on expert contract organizations.

Key Market Players

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet (Pty) Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

Report Scope:

In this report, the Global Veterinary CRO And CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO And CDMO Market, By Animal:

  • Companion Animals
  • Livestock Animals

Veterinary CRO And CDMO Market, By Service:

  • Discovery
  • Development
  • Manufacturing
  • Packaging & Labeling
  • Market Approval & Post Marketing

Veterinary CRO And CDMO Market, By Application:

  • Pharmaceuticals
  • Biologics
  • Medical Devices
  • Others

Veterinary CRO And CDMO Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary CRO And CDMO Market.

Available Customizations:

Global Veterinary CRO And CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary CRO And CDMO Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal (Companion Animals, Livestock Animals)
    • 5.2.2. By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing)
    • 5.2.3. By Application (Pharmaceuticals, Biologics, Medical Devices, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Veterinary CRO And CDMO Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal
    • 6.2.2. By Service
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary CRO And CDMO Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Application
    • 6.3.2. Mexico Veterinary CRO And CDMO Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Application
    • 6.3.3. Canada Veterinary CRO And CDMO Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Application

7. Europe Veterinary CRO And CDMO Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal
    • 7.2.2. By Service
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary CRO And CDMO Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Veterinary CRO And CDMO Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Veterinary CRO And CDMO Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Veterinary CRO And CDMO Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Veterinary CRO And CDMO Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Application

8. Asia-Pacific Veterinary CRO And CDMO Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal
    • 8.2.2. By Service
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary CRO And CDMO Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Application
    • 8.3.2. India Veterinary CRO And CDMO Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Application
    • 8.3.3. South Korea Veterinary CRO And CDMO Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Application
    • 8.3.4. Japan Veterinary CRO And CDMO Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Veterinary CRO And CDMO Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Application

9. South America Veterinary CRO And CDMO Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal
    • 9.2.2. By Service
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary CRO And CDMO Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Veterinary CRO And CDMO Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Veterinary CRO And CDMO Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Application

10. Middle East and Africa Veterinary CRO And CDMO Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal
    • 10.2.2. By Service
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary CRO And CDMO Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Veterinary CRO And CDMO Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Veterinary CRO And CDMO Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fortrea Holdings Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Charles River Laboratories International, Inc.
  • 15.3. Clinvet (Pty) Ltd.
  • 15.4. KLIFOVET GmbH
  • 15.5. Veterinary Research Management, Inc.
  • 15.6. VETSPIN SRL
  • 15.7. Inotiv, Inc.
  • 15.8. IDEXX Laboratories, Inc.
  • 15.9. Vetio Animal Health
  • 15.10. TriRx Pharmaceutical Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer